Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt · Delayed Price · Currency is EGP 1,259.56
-4.56 (-0.36%)
At close: Aug 5, 2026
EGX:AXPH Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 416.06 | 285.8 | 150.04 | 90.51 | 153.75 | 52.12 |
Cash & Short-Term Investments | 416.06 | 285.8 | 150.04 | 90.51 | 153.75 | 52.12 |
Cash Growth | 142.74% | 90.49% | 65.77% | -41.13% | 194.98% | -68.72% |
Accounts Receivable | 335.2 | 120.65 | 62.7 | 66.91 | 113.61 | 106.2 |
Other Receivables | 104.91 | 95.44 | 87.2 | 28.14 | 22.65 | 27.34 |
Receivables | 507.11 | 265.29 | 186.19 | 144.18 | 168.13 | 166.16 |
Inventory | 434.89 | 607.36 | 522.51 | 345.41 | 271.51 | 307.64 |
Prepaid Expenses | 0.19 | 0.19 | 0.19 | 0.27 | 0.36 | 0.05 |
Restricted Cash | - | - | - | - | 0 | 0.86 |
Other Current Assets | - | - | -0 | -0 | 0 | -0 |
Total Current Assets | 1,358 | 1,159 | 858.93 | 580.36 | 593.76 | 526.82 |
Property, Plant & Equipment | 409.67 | 366 | 379.71 | 340.24 | 279.06 | 264.29 |
Long-Term Investments | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 |
Other Long-Term Assets | - | - | - | -0 | - | - |
Total Assets | 1,770 | 1,527 | 1,241 | 922.99 | 875.21 | 793.49 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 374.43 | 309.36 | 277.85 | 139.28 | 160.86 | 92.14 |
Accrued Expenses | 6.6 | 6.07 | 5.17 | 4.16 | 4.32 | 6.45 |
Short-Term Debt | 6.35 | 4.08 | 0.81 | 12.03 | 9.11 | 1.77 |
Current Unearned Revenue | 0.76 | 0.61 | 0.24 | 1.25 | - | - |
Other Current Liabilities | 287.6 | 203.67 | 152.4 | 91.7 | 78.13 | 99.48 |
Total Current Liabilities | 675.74 | 523.8 | 436.47 | 248.42 | 252.43 | 199.83 |
Long-Term Deferred Tax Liabilities | 8.95 | 8.95 | 9.57 | 14.44 | 10.18 | 7.46 |
Total Liabilities | 684.7 | 532.75 | 446.04 | 262.85 | 262.6 | 207.29 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 50 | 50 | 50 | 50 | 50 | 50 |
Retained Earnings | 1,028 | 936.98 | 738.24 | 604.42 | 494.73 | 530.88 |
Comprehensive Income & Other | 7.3 | 7.3 | 6.74 | 5.72 | 67.87 | 5.32 |
Shareholders' Equity | 1,086 | 994.28 | 794.98 | 660.14 | 612.6 | 586.2 |
Total Liabilities & Equity | 1,770 | 1,527 | 1,241 | 922.99 | 875.21 | 793.49 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 6.35 | 4.08 | 0.81 | 12.03 | 9.11 | 1.77 |
Net Cash (Debt) | 409.71 | 281.72 | 149.22 | 78.48 | 144.63 | 50.35 |
Net Cash Growth | 141.21% | 88.79% | 90.14% | -45.74% | 187.27% | -68.29% |
Net Cash Per Share | 81.94 | 56.34 | 29.84 | 15.70 | 28.93 | 10.07 |
Filing Date Shares Outstanding | 5 | 5 | 5 | 5 | 5 | 5 |
Total Common Shares Outstanding | 5 | 5 | 5 | 5 | 5 | 5 |
Working Capital | 682.51 | 634.85 | 422.46 | 331.94 | 341.33 | 326.99 |
Book Value Per Share | 217.12 | 198.86 | 159.00 | 132.03 | 122.52 | 117.24 |
Tangible Book Value | 1,086 | 994.28 | 794.98 | 660.14 | 612.6 | 586.2 |
Tangible Book Value Per Share | 217.12 | 198.86 | 159.00 | 132.03 | 122.52 | 117.24 |
Land | 0.08 | 0.08 | - | - | - | 0.08 |
Buildings | 197.43 | 197.53 | - | - | - | 38.75 |
Machinery | 489.22 | 479.43 | - | - | - | 306.41 |
Construction In Progress | 107 | 38.08 | - | - | - | 134.55 |